Changes in lifestyle after hypertension diagnosis in Canada

被引:6
作者
Neutel, C. Ineke [1 ,2 ]
Campbell, Norm R. C. [3 ,4 ]
机构
[1] Publ Hlth Agcy Canada, Ctr Chron Dis Prevent & Control, Ottawa, ON K1A 0K9, Canada
[2] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada
[3] Univ Calgary, Fac Med, Dept Med, Calgary, AB, Canada
[4] Univ Calgary, Fac Med, Dept Pharmacol & Therapeut, Calgary, AB, Canada
关键词
hypertension; lifestyle drugs;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lifestyle modification should be an important part of therapy when hypertension is first diagnosed, with or without starting antihypertensive medication. The objective of the present study was to determine the extent to which recently diagnosed hypertensive Canadians modify their lifestyles and to examine how lifestyle modification relates to antihypertensive medication use. The longitudinal National Population Health Survey in Canada was conducted between 1994 and 2002, including five interview cycles at two-year intervals. During this time, 1281 persons reported hypertension in one cycle but not in the previous cycle, and were considered to be new hypertensive patients. Information collected included body mass index, smoking, alcohol consumption, physical inactivity and medication use. The main lifestyle modification associated with newly diagnosed hypertensive patients was smoking cessation, with a 18.6% relative risk reduction (RRR). A smaller change was seen in decreasing physical inactivity (RRR 6.2%). Persons not taking antihypertensive medication were not more likely to make lifestyle improvements. Paradoxically, new hypertensive patients showed increased numbers in the obese category (RRR -9.6%). Weight gain was especially marked among antihypertensive medication users and largest in female beta-blocker users (RRR -36.6%). If confirmed, this needs to be considered when prescribing to overweight people. In general, a greater effort is required to manage hypertension by lifestyle risk modification with or without antihypertensive medication.
引用
收藏
页码:199 / 204
页数:6
相关论文
共 21 条
  • [1] Lifestyle modification as a means to prevent and treat high blood pressure
    Appel, LJ
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (07): : S99 - S102
  • [2] Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083
  • [3] Does the Y chromosome make a difference? Gender differences in attempts to change cardiovascular disease risk factors
    Assaf, AR
    Parker, D
    Lapane, KL
    Coccio, E
    Evangelou, E
    Carleton, RA
    [J]. JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2003, 12 (04): : 321 - 330
  • [4] Campbell NRC, 1999, CAN MED ASSOC J, V160, P1341
  • [5] Choinière R, 2000, CAN MED ASSOC J, V162, pS13
  • [6] Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levels
    Critchley, JA
    Capewell, S
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2003, 57 (04) : 243 - 247
  • [7] Dzien A, 2003, AGE AGEING, V32
  • [8] Hypertensive therapy: Part II
    Franco, V
    Oparil, S
    Carretero, OA
    [J]. CIRCULATION, 2004, 109 (25) : 3081 - 3088
  • [9] INCREASED ABSENTEEISM FROM WORK AFTER DETECTION AND LABELING OF HYPERTENSIVE PATIENTS
    HAYNES, RB
    SACKETT, DL
    TAYLOR, DW
    GIBSON, ES
    JOHNSON, AL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (14) : 741 - 744
  • [10] Hemmelgarn BR, 2004, CAN J CARDIOL, V20, P31